Potential peptide targets in immunotherapy for pancreatic carcinoma
| Antigen | Approximate % incidence | Reference |
|---|---|---|
| KAI1 | 89 | 23 |
| MUC1 | 80 | 24 |
| Her2/neu | 50 | 25 |
| PAP | 20 | 26 |
| NT-3 | 72 | 27 |
| c-fos | 75 | 28 |
| Ki-ras | 90 | 29 |
| p53 | 67 | 30 |
| CA 19-9 | 76 | 31 |
| CA 17.1 | 90 | 31 |
| TPA | 85 | 32 |
| TUM2-PK | 71 | 33 |
| CEA | 39 | 33 |
PAP, pancreatic associated protein; NT-3, neurotrophin-3; TPA, tissue polypeptide antigen; CEA, carcinoembryonic antigen.